AI Verdict
MSFT has stronger fundamentals based on our AI analysis.
IOBT vs MSFT Fundamental Comparison
| Metric | IOBT | MSFT |
|---|---|---|
| Revenue | N/A | $158.9B |
| Net Income | $-57.0M | $66.2B |
| Net Margin | N/A | 41.7% |
| ROE | -6,258.6% | 16.9% |
| ROA | -142.7% | 10.0% |
| Current Ratio | 2.01x | 1.39x |
| Debt/Equity | 18.29x | 0.10x |
| EPS | $-0.86 | $8.87 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
IOBT vs MSFT: Frequently Asked Questions
Is IOBT or MSFT a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), MSFT has stronger fundamentals. IOBT is rated STRONG SELL (95% confidence) while MSFT is rated BUY (91% confidence). This is not investment advice.
How does IOBT compare to MSFT fundamentally?
IO Biotech, Inc. has ROE of -6,258.6% vs MICROSOFT CORP's 16.9%. Net margins are N/A vs 41.7% respectively.
Which stock pays higher dividends, IOBT or MSFT?
IOBT has a dividend yield of N/A or no dividend while MSFT has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in IOBT or MSFT for long term?
For long-term investing, consider that IOBT has STRONG SELL rating with 95% confidence, while MSFT has BUY rating with 91% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about IOBT vs MSFT?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For IOBT vs MSFT, the AI consensus favors MSFT based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.